Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04951076 |
|---|---|
| Brief Title: | A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD) (ATTUNE) |
| First Submitted : | June 27, 2021 |
| First Submitted that Met QC Criteria : | June 27, 2021 |
| First Posted : | July 6, 2021 |
| Last Update Submitted that Met QC Criteria : | May 1, 2023 |
| Last Update Posted : | May 3, 2023 |